After 20 Years and 30,947 Attempts, Scientists Hit the Limits of Mouse Cloning
Key Takeaways
- ▸Serial cloning in mice can proceed for at least 58 generations before cloning efficiency drops to near zero, contradicting earlier concerns that cloning would fail within a few generations
- ▸Mutations accumulate at 3.1 times the rate of natural reproduction during repeated cloning, with over 3,400 mutations by generation 57
- ▸Cloned mice remained phenotypically healthy with normal lifespans despite carrying high mutation loads, suggesting the mutations may not immediately cause fitness defects
Summary
Researchers at RIKEN's Wakayama Laboratory, led by Dr. Teruhiko Wakayama and Dr. Sayaka Wakayama, have completed a groundbreaking 20-year study on serial cloning in mice, publishing their final results in 2026. Beginning in 2005, the team repeatedly cloned mice from previously cloned mice, creating 58 successive generations through over 30,000 cloning attempts. The study revealed that while cloned mice remained healthy and lived normal lifespans, cloning efficiency declined significantly after generation 40 and became nearly impossible by generation 58.
Using advanced whole-genome sequencing unavailable when the project began, researchers discovered that mutations accumulated at roughly 3.1 times the rate of natural reproduction—with generation 57 mice carrying over 3,400 single-base mutations compared to just 752 in 62 naturally-bred generations. The accumulation of genetic mutations ultimately rendered the mouse cells unable to produce viable clones, establishing a biological limit to serial cloning. The study provides critical insights into the long-term viability and genetic stability of cloned organisms, with implications for both basic biological research and cloning technology.
- The project required unprecedented technical skill and persistence over two decades, including survival through lab relocations, earthquakes, and the COVID-19 pandemic
Editorial Opinion
This landmark study demonstrates both the remarkable resilience of cloning as a technology and the fundamental constraints imposed by biological replication. While the Wakayama group's findings confirm that serial cloning can be sustained far longer than originally expected, the ultimate failure of the system around generation 58 suggests that accumulated mutations impose a practical ceiling on cloning indefinitely. The work underscores why such long-term experiments, though laborious and expensive, remain invaluable for understanding biological limits—and why only a handful of labs worldwide possess the expertise to conduct them.
